全球氟伏沙明市场 - 行业趋势及 2029 年预测

市场分析和洞察：全球氟伏沙明市场

氟伏沙明市场预计将在 2022-2029 年的预测期内实现市场增长。Data Bridge Market Research 分析称，在上述预测期内，市场复合年增长率将达到 4%。

氟伏沙明是一种选择性血清素再摄取抑制剂 (SSRI) 抗抑郁药。这种药物通过增加大脑中的血清素水平起作用。它是一种仿制药，有两种形式，包括片剂和胶囊。Luvox 和 Luvox CR 是这种药物的品牌名称。这种药物用于治疗强迫症、抑郁症和创伤后应激障碍。

焦虑和抑郁症患病率的上升将成为氟伏沙明市场扩张的主要推动力。此外，老年人口的增加、医疗支出的增加以及患有强迫症的患者数量的增加都是扩大氟伏沙明市场的因素。其他因素包括社交焦虑症发病率的上升、生活方式的改变和意识的提高，都将对市场增长率产生积极影响。

此外，研发活动的增加和正在进行的临床试验将为 2021-2028 年预测期内的氟伏沙明市场提供有利的机会。

然而，药物成本高昂，以及与氟西汀相关的副作用，如腹泻、头痛、消化不良、恶心、口干、胃痛、体重减轻、头晕、疲劳等，将阻碍市场增长。缺乏认知将在上述预测期内进一步挑战氟伏沙明市场。

This fluvoxamine market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the fluvoxamine market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Fluvoxamine Market Scope and Market Size

The fluvoxamine market is segmented on the basis of drug class, application, demographic, dosage form, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of drug class, the fluvoxamine market is segmented into antidepressant, selective serotonin reuptake inhibitor (SSRI) and others.
• On the basis of application, the fluvoxamine market is segmented into obsessive-compulsive disorder, depression, post-traumatic stress disorder and others.
• On the basis of demographic, the fluvoxamine market is segmented into adult, pediatric and geriatric.
• On the basis of dosage form, the fluvoxamine market is segmented into tablet, capsule and others. Tablet segment is further sub-segmented into 100mg, 25mg, and 50mg. Capsule segment is further sub-segmented into 100mg, and 150mg.
• On the basis of route of administration, the fluvoxamine market is segmented into oral and others.
• On the basis of end-users, the fluvoxamine market is segmented into clinic, hospital and others.

The fluvoxamine market is also segmented on the basis of distribution channel into hospital pharmacy, retail pharmacy and online pharmacy.

Fluvoxamine Market Country Level Analysis

Fluvoxamine market is analyzed and market size information is provided by the country, drug class, application, demographic, dosage form, route of administration, end-users and distribution channel as referenced above.

The countries covered in the fluvoxamine market report are the U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa.

North America dominates the fluvoxamine market due to the presence of major key players, high disposable income and well-developed healthcare infrastructure in this region. Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the increasing research and development activities and rise in the prevalence of obsessive-compulsive disorder in this region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

Fluvoxamine market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

Competitive Landscape and Global Fluvoxamine Market Share Analysis

Fluvoxamine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to fluvoxamine market research.

氟伏沙明市场的一些主要参与者包括 Teva Pharmaceutical Industries Ltd.、Abbott、Livzon、Solvay、Sun Pharmaceutical Industries Ltd.、Novartis AG、Mylan NV、Merck KGaA、.、Apotex Inc.、Bay Pharma GmbH、Synthon International Holding BV、TAIWAN BIOTECH CO., LTD.、Shandong Octagon Chemicals Limited、Lake Chemicals Private Ltd.、ZCL Chemicals Ltd.、Ra Chem Pharma Ltd.、RL Fine Chem Pvt. Ltd. 和 Mehta API Pvt Ltd. 等。

SKU-67395